Medline, Inc. Class A MDLN
NASDAQ · United States · Health Technology
$34.70-0.28 (-0.80%)
Market closed· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Market closed· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
| Quarter | Report date | Actual EPS | Estimated EPS | EPS surprise | Actual revenue | Revenue surprise | Price reaction |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 2026-08-05 | 0.50 | 0.35 | +41.9% | $7.69B | +2.2% | -17.9%$42.04→$34.51 |
| Q1 2026 | 2026-05-06 | 0.33 | 0.29 | +13.8% | — | — | -7.6%$45.32→$41.86 |
| Q4 2025 | 2026-02-25 | 0.31 | 0.24 | +29.2% | — | — | -2.2%$49.99→$48.89 |
The price reaction is the change from the last close before the announcement date to the first close after it - the report may land before the open, during the session or after the close, so this window covers all three. Not investment advice.